Executive Director, Head of Corporate Development

At Medison, we offer hope to patients suffering from rare and severe diseases. Through strategic partnerships with best-in-class biotech companies, we commercialize innovative therapies across global markets. Our culture is rooted in care, agility, collaboration, and innovation, and we’re united by a shared purpose to make a meaningful difference. If you’re passionate about driving growth and delivering breakthrough innovation to patients, we invite you to be part of our journey.

Responsibilities

• Lead and execute valuation deal models across all types of transactions. Serve as Medison’s hands‑on Center of Excellence for all valuation matters in the company.
• Identify, evaluate, and execute strategic partnerships and other key transactions in support of Medison’s growth. Lead cross‑functional teams through diligence efforts, ensuring rigorous analysis and internal collaboration.
• Develop and maintain a robust pipeline of strategic opportunities, aligned with Medison’s long‑term objectives. Build and manage relationships with internal and external stakeholders, including investment banks and potential biotech partners.
• Work in collaboration with Corporate Strategy and other functions to support Medison’s Long‑Range Plan, BOD‑related analyses and other financial assessments.
• Spearhead post‑deal analysis, insights, and implementation of key learnings in BD practices.
• Serve as a key thought partner to the CBO and broader Executive Team, contributing to long‑term value creation.
• Mentor, manage, and develop a high‑performing corporate development team, cultivating an environment of Leadership, Collaboration, and Excellence.
• Collaborate and lead the integration of corporate, scientific, and commercial assessments into comprehensive deal analysis.
• Represent Medison externally at key industry conferences and with potential biotech partners, serving as a visible ambassador for the company’s growth strategy.

Requirements

• 10-15 years experience in corporate/business development within the biotech/pharma industry, investment banking, management consulting (Big 3), private equity, and royalty firms.
• Demonstrated successful track record in leading and closing late‑stage and/or commercial‑stage transactions with biotech/pharma companies.
• Extensive knowledge of financial analysis, valuation methodologies (P&Ls, DCF, NPV, IRR, risk adjustments, etc.) and deal structuring. M&A experience strongly preferred, but not mandatory.
• MBA, or other advanced degree. Additional scientific degree a plus, but not mandatory.
• Entrepreneurial mindset, highly driven, hands‑on, excited by fast‑paced hyper‑growth company.
• Excellent communication skills and ability to engage with C‑level executives.
• Inspirational leader. Collaborative – builds trust and alignment across teams and seniority.

Benefits

• The opportunity to make an impact at the enterprise level at a hyper‑growth company.
• A patient‑centric, mission‑driven culture that values collaboration, excellence and ownership.
• Competitive compensation and benefits package.

Location

United States, East Coast based (Greater NY or Greater Boston preferred; remote position).

Reports to: Chief Business Officer

Expected Base Pay Range (USD): $250,000‑$330,000 per annum. The successful candidate’s starting base pay will be determined based on job‑related skills, experience, qualifications, work location, and market conditions. The expected base pay range for this role may be modified based on market conditions.

Medison is committed to building a diverse and inclusive workplace. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability, or protected veteran status.

Application Deadline: Thursday, March 19th, 2026

#J-18808-Ljbffr